Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves’ disease patients with hyperthyroidism or subjects with euthyroidism-Reference-Cited by-同舟云学术

Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves’ disease patients with hyperthyroidism or subjects with euthyroidism

Published:2019-03 Issue:11 Volume:98 Page:e14862
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Tseng Fen-Yu,Chen Yen-Ting,Chi Yu-Chiao,Chen Pei-Lung,Yang Wei-Shiung

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference48 articles.

1. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes;Clemmons;Endocrinol Metab Clin North Am,2012

2. The role of insulin-like growth factor-1 and its binding proteins in glucose homeostasis and type 2 diabetes;Rajpathak;Diabetes Metab Res Rev,2009

3. The thermogenic effect of thyroid hormone and its clinical implications;Silva;Ann Intern Med,2003

4. Insulin-like growth factor type 1 concentrations in hyperthyroid cats before and after treatment with thiamazole;Rochel;J Feline Med Surg,2018

5. Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study;Völzke;J Clin Endocrinol Metab,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth hormone-secreting pituitary adenoma combined with Graves’ disease: retrospective case series and literature review;Endocrine Connections;2024-02-13

2. IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome;Cell Reports;2022-12

3. Growth Hormone/Insulin-like Growth Factor 1 Axis Associated with Modifier Factors in Children with Sickle Cell Anemia;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-08

4. Analysis of epidemiological association patterns of serum thyrotropin by combining random forests and Bayesian networks;PLOS ONE;2022-07-21

5. Teprotumumab-associated chronic hearing loss screening and proposed treatments;BMJ Case Reports;2022-04